Simtra BioPharma Opens $250 Million Manufacturing Expansion in Bloomington, Indiana

Simtra BioPharma Solutions, a contract development and manufacturing organization focused on sterile injectables, has opened Building H, a more than $250 million expansion of its Bloomington, Indiana manufacturing campus. Company leaders were joined at a November 9 ribbon-cutting by Indiana Governor Mike Braun, Bloomington Mayor Kerry Thomson and economic development officials.

The 153,000-square-foot building adds prefilled syringe, vial and lyophilization capabilities. The expansion is also expected to create hundreds of high-quality jobs in Bloomington.

Franco Negron, chief executive officer of Simtra BioPharma Solutions said:

“Building H represents much more than additional manufacturing capacity. It is an important milestone in the growth strategy we are executing across Simtra. We are investing in the capacity, technology and infrastructure our customers need to develop and manufacture increasingly complex sterile injectable medicines.”

Part of a broader network expansion

Building H is part of Simtra’s global growth strategy, which also includes more than $125 million invested in expanded manufacturing capacity in Halle, Germany, and an initial investment of more than $150 million at its Bloomington Park Campus. Across its U.S. and European network, Simtra plans to grow from 11 filling lines to 18 by 2027.

Ray Guidotti, chief operating officer of Simtra BioPharma Solutions said:

“Our customers are planning years ahead, and they need manufacturing partners that can do the same. Building H gives us significant new capacity in Bloomington today to go along with our expansion in Halle, while investment in our new Park campus creates additional options for the future.”